Beta-blocker and calcium channel blocker combination

This page covers all Beta-blocker and calcium channel blocker combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 adrenergic receptor; L-type calcium channel.

Targets

Beta-1 adrenergic receptor; L-type calcium channel

Marketed (1)

• Nebivolol+Diltiazem · Korea University Anam Hospital · Cardiovascular
  Nebivolol and diltiazem work together as a beta-blocker and calcium channel blocker to reduce heart rate, blood pressure, and cardiac workload.

Patent intelligence

• beta blocker and calcium channel blocker combination patent landscape — aggregated cliff calendar, attackable patents, originator estates